Full Answer
How do I Sell my J and J stock?
When you decide to sell your J and J stock, the process is mostly the same as buying-all you need to do is log into your brokerage account and enter a sell order online with the amount of shares or dollar value you wish to sell. As with purchases, when you sell stock you can do so at the market price or with a set limit price.
Who bought out J&J's Cordis?
J&J sold its Cordis business to Cardinal Health for about $2 billion in October 2015. J&J sold its LifeScan diabetes device unit to private equity firm, Platinum Equity in October 2018 and its Advanced Sterilization Products unit to Fortive Corporation in April 2019.
How much is Johnson & Johnson's dividend?
The current dividend yield for Johnson & Johnson (NYSE:JNJ) is 2.67%. Learn more on JNJ's dividend yield history. How much is Johnson & Johnson's annual dividend? The annual dividend for Johnson & Johnson (NYSE:JNJ) is $4.52. Learn more on JNJ's annual dividend history.
How much of Johnson&Johnson stock is owned by insiders?
Only 0.30% of the stock of Johnson & Johnson is held by insiders. 67.14% of the stock of Johnson & Johnson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
See more
Is JNJ a Buy Sell or Hold?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Is JNJ a good long term investment?
JNJ delivered favorable financial results at the year-end of 2021, with its growth substantially larger than that of competitors. With its steadily growing EPS, the company's dividend yield of 2.57% stands significantly above the S&P 500 average of 1.57%, adding to the reasons why JNJ is a clear market favorite.
How often does Johnson and Johnson pay dividends?
4 dividends per yearDividend Summary There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.3.
Will JNJ stock go up?
Johnson & Johnson (NYSE:JNJ) The 17 analysts offering 12-month price forecasts for Johnson & Johnson have a median target of 187.00, with a high estimate of 215.00 and a low estimate of 173.00. The median estimate represents a +5.69% increase from the last price of 176.93.
Is Johnson and Johnson going out of business?
J&J itself isn't bankrupt—instead, it has split off a new unit essentially designed to go broke paying legal liabilities. It's part of a maneuver to deal with about 38,000 lawsuits, mostly filed by women who claim one of the company's oldest products, baby powder, causes ovarian cancer.
Is JNJ a good stock to buy 2022?
Expectations For 2022 The firm expects to earn $10.15-$10.35 per share on $94.8 billion to $95.8 billion in sales. For the year, JNJ stock analysts call for adjusted profit of $10.27 per share on $96.49 billion in sales. Both measures would climb less than 10% year over year.
What stock pays the highest dividend?
Most American dividend stocks pay investors a set amount each quarter, and the top ones increase their payouts over time, so investors can build an annuity-like cash stream....25 high-dividend stocks.SymbolCompany NameDividend YieldMOAltria Group Inc.6.66%OKEONEOK Inc.5.68%UVVUniversal Corp.4.96%LAMRLamar Advertising Co4.90%21 more rows
How many times has Johnson and Johnson stock split?
Johnson and Johnson (JNJ) has 6 splits in our Johnson and Johnson stock split history database. The first split for JNJ took place on May 18, 1970. This was a 3 for 1 split, meaning for each share of JNJ owned pre-split, the shareholder now owned 3 shares.
Whats a good dividend yield?
2% to 4%What is a good dividend yield? In general, dividend yields of 2% to 4% are considered strong, and anything above 4% can be a great buy—but also a risky one. When comparing stocks, it's important to look at more than just the dividend yield.
Is it good to buy Johnson and Johnson stock?
Along with the results, JNJ also announced a hike in its quarterly dividend by 6.6%, to $1.13 per share. This marks the company's 60th consecutive yearly dividend increase. The company's efforts in growing its business through new innovative products and drugs are why I believe Johnson & Johnson is worth investing in.
Is JNJ undervalued?
The company's cash flows seem to be undervalued, and investors might be able to take advantage of the recent market pessimism. So while earnings quality is important, it's equally important to consider the risks facing Johnson & Johnson at this point in time.
Is Johnson and Johnson a good company?
Johnson & Johnson is the world's largest health care company. It is also the highest paid drug company in the world. J&J remains at the top of the Big Pharma list of powerful corporations with more than $82 billion in annual revenue in 2020. Its top products include Tylenol, Stelara, Invega and various medical devices.
Is Johnson & Johnson stock a Buy, Sell or Hold?
Johnson & Johnson stock has received a consensus rating of buy. The average rating score is Aaa and is based on 18 buy ratings, 6 hold ratings, and...
What was the 52-week low for Johnson & Johnson stock?
The low in the last 52 weeks of Johnson & Johnson stock was 155.72. According to the current price, Johnson & Johnson is 110.81% away from the 52-w...
What was the 52-week high for Johnson & Johnson stock?
The high in the last 52 weeks of Johnson & Johnson stock was 186.69. According to the current price, Johnson & Johnson is 92.43% away from the 52-w...
What are analysts forecasts for Johnson & Johnson stock?
The 24 analysts offering price forecasts for Johnson & Johnson have a median target of 185.04, with a high estimate of 210.00 and a low estimate of...
What are Johnson and Johnson products?
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands ; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Where is Johnson and Johnson located?
Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Read More.
What is Johnson & Johnson's dividend yield?
The current dividend yield for Johnson & Johnson (NYSE:JNJ) is 2.63%. Learn more
How much is Johnson & Johnson's annual dividend?
The annual dividend for Johnson & Johnson (NYSE:JNJ) is $4.24. Learn more
How often does Johnson & Johnson pay dividends?
Johnson & Johnson (NYSE:JNJ) pays quarterly dividends to shareholders.
When is Johnson & Johnson's next dividend payment?
Johnson & Johnson's next quarterly dividend payment of $1.06 per share will be made to shareholders on Tuesday, March 8, 2022.
When was Johnson & Johnson's most recent dividend payment?
Johnson & Johnson's most recent quarterly dividend payment of $1.06 per share was made to shareholders on Tuesday, December 7, 2021.
Is Johnson & Johnson's dividend growing?
Over the past three years, Johnson & Johnson's dividend has grown by 18.36%.
What track record does Johnson & Johnson have of raising its dividend?
Johnson & Johnson (NYSE:JNJ) has increased its dividend for the past 60 consecutive years.
What is Johnson and Johnson's biggest strength?
Johnson & Johnson’s biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. It comprises some 250 subsidiaries, which clearly means that the business is extremely well diversified. Its diversification helps it to withstand economic cycles more effectively. Meanwhile, J&J has one of the largest research and development (R&D) budget among pharma companies.#N#New Brunswick, NJ based J&J’s worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. In 2020, these segments contributed 55%, 38% and 17%, respectively, to the ...
Is ZacksTrade a separate company?
ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
Ownership
- Low
- High
- Open
Release
| DATE | OPEN | HIGH | LOW |
|---|---|---|---|
| Jul 23, 2021 | 171.00 | 172.18 | 170.38 |
| Jul 22, 2021 | 169.36 | 171.07 | 168.65 |
| Jul 21, 2021 | 169.30 | 169.69 | 167.48 |
| Jul 20, 2021 | 166.90 | 170.81 | 166.84 |
| Jul 19, 2021 | 166.48 | 168.19 | 165.32 |
| Jul 16, 2021 | 168.34 | 169.09 | 167.95 |
| Jul 15, 2021 | 169.30 | 169.90 | 167.72 |
| Jul 14, 2021 | 170.00 | 170.83 | 169.04 |
Sales
- Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol \"JNJ.\" Johnson & Johnson's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.04%), Northern Trust Corp (1.30%), Boston Partners (0.46%), Sumitomo Mitsui Trust Holdings Inc. (0.41%), Swiss National Bank (0.37%) an…
Risks
- Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, July 16th 2019. View Earnings Estimates for Johnson & Johnson.
Ratings
- Johnson & Johnson issued an update on its FY19 earnings guidance on Tuesday, April, 16th. The company provided earnings per share (EPS) guidance of $8.53-8.63 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.59. The company issued revenue guidance of $80.4-81.2 billion, compared to the consensus revenue estimate of $81.17 …
Reviews
- 11 brokerages have issued 1-year price targets for Johnson & Johnson's shares. Their forecasts range from $129.00 to $157.00. On average, they expect Johnson & Johnson's share price to reach $146.00 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.
Business
- 11 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Johnson & Johnson in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Johnson & Johnson.